MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$247,927
Prepaid clinical trial
costs
$81,742
Cash and cash
equivalents
$13,183,259
Non-current prepaid
clinical trial costs
$819,721
Total current assets
$13,512,928
Total assets
$14,332,649
Total liabilities and
stockholders equity
$14,332,649
Total stockholders'
equity
$4,549,735
Total liabilities
$9,782,914
Accumulated deficit
-$180,770,273
Additional paid-in capital
$185,310,390
Warrant liabilities
$44,506
Total current
liabilities
$9,738,408
Common stock, par value
of 0.0001...
$9,618
Other accrued
liabilities
$630,471
Accrued compensation
$784,956
Accrued clinical
expenses
$2,891,175
Accounts payable
$5,431,806
Back
Back
Balance Sheet
source: myfinsight.com
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)